Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers

J Mol Biol. 2012 Aug 24;421(4-5):517-24. doi: 10.1016/j.jmb.2012.01.013. Epub 2012 Jan 28.

Abstract

The green tea compound epigallocatechin-3-gallate (EGCG) inhibits Alzheimer's disease β-amyloid peptide (Aβ) neurotoxicity. Solution-state NMR allows probing initial EGCG-Aβ interactions. We show that EGCG-induced Aβ oligomers adopt a well-defined structure and are amenable for magic angle spinning solid-state NMR investigations. We find that EGCG interferes with the aromatic hydrophobic core of Aβ. The C-terminal part of the Aβ peptide (residues 22-39) adopts a β-sheet conformation, whereas the N-terminus (residues 1-20) is unstructured. The characteristic salt bridge involving residues D23 and K28 is present in the structure of these oligomeric Aβ aggregates as well. The structural analysis of small-molecule-induced amyloid aggregates will open new perspectives for Alzheimer's disease drug development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / chemically induced*
  • Alzheimer Disease / physiopathology
  • Amyloid beta-Peptides / chemistry*
  • Amyloid beta-Peptides / metabolism
  • Catechin / adverse effects
  • Catechin / analogs & derivatives*
  • Catechin / metabolism
  • Humans
  • Magnetic Resonance Spectroscopy
  • Neuroprotective Agents / adverse effects*
  • Neuroprotective Agents / metabolism
  • Protein Conformation
  • Protein Denaturation
  • Protein Multimerization

Substances

  • Amyloid beta-Peptides
  • Neuroprotective Agents
  • Catechin
  • epigallocatechin gallate